EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neurofilament light chain as a marker of peripheral nerve damage in vasculitic neuropathy? A cross‐compartmental correlation analysis in patients undergoing nerve biopsy

Simon Streit, Jenny Meinhardt, Niclas Gimber, John Kestenbach, Christin Siewert, Jan Schmoranzer, Christian Meisel, Klemens Ruprecht, Frank L Heppner, Péter Körtvélyessy, Werner Stenzel iD

Brain Pathology · 2026

DOI: 10.1111/bpa.70038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Pathology, 2026. Verfasst von Simon Streit und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Be…. Hauptthemen laut MEDLINE: Neurofilament Proteins, Peripheral Nervous System Diseases, Vasculitis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: John Grube Foundation e.V., European Partnership on Metrology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vasculitic neuropathy remains challenging to diagnose and monitor because of its heterogeneous clinical and laboratory presentation. Blood‐based biomarkers indicating nerve damage could serve as an additional diagnostic tool to ensure early diagnosis, precise therapeutic monitoring, and a more targeted anti‐inflammatory treatment. A potential marker for this purpose is neurofilament light chain (NfL), a marker of neuroaxonal damage that is used as a biomarker in several diseases of the central and peripheral nervous system. NfL has also been suggested to reflect disease activity in patients with vasculitic neuropathy. However, its biodynamics and link to degeneration of peripheral nerve tissue remain unconfirmed. To investigate the usefulness of NfL as a marker of peripheral nerve damage in this context, we retrospectively assembled a cohort of 35 patients undergoing sural nerve biopsies (including patients with vasculitic neuropathy and other neuropathies). We then measured NfL in serum samples cryoarchived at the time of biopsy and correlated NfL levels with histological parameters. For our histological analysis, we quantified parameters of acute axonal degeneration and chronic axonal loss using a combination of manual, threshold‐based, and supervised learning‐based analyses. We found a significant positive correlation between parameters of acute axonal degeneration and serum‐NfL levels that persisted after adjusting for age and concomitant central nervous system disease. We did not find a similar correlation with parameters of chronic axonal loss quantified in nerve biopsies. These findings support the value of NfL as a marker for acute axonal degeneration in patients with vasculitic neuropathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofilament ProteinsPeripheral Nervous System DiseasesVasculitisHumansFemaleMaleMiddle AgedBiomarkersAgedRetrospective StudiesAdultBiopsySural NerveAged, 80 and over

Stichwörter der Autor:innen

biomarkerhistopathologynerve biopsyneurofilament light chain (NfL)vasculitic neuropathyvasculitis

Substanzen

Neurofilament ProteinsBiomarkersneurofilament protein L

Autor:innen und Institutionen

  • Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Advanced Medical BioImaging Core Facility-AMBIO, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Labor Berlin-Charité Vivantes GmbH, Berlin, Germany.
  • Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
  • German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.

ORCID-Profile: Werner Stenzel

Förderung

  • John Grube Foundation e.V.
  • European Partnership on Metrology

Zitieren

APA

Streit, S., Meinhardt, J., Gimber, N., Kestenbach, J., Siewert, C., Schmoranzer, J., Meisel, C., Ruprecht, K., Heppner, F. L., Körtvélyessy, P., & Stenzel, W. (2026). Neurofilament light chain as a marker of peripheral nerve damage in vasculitic neuropathy? A cross‐compartmental correlation analysis in patients undergoing nerve biopsy. Brain Pathology. https://doi.org/10.1111/bpa.70038

Vancouver

Streit S, Meinhardt J, Gimber N, Kestenbach J, Siewert C, Schmoranzer J, et al. Neurofilament light chain as a marker of peripheral nerve damage in vasculitic neuropathy? A cross‐compartmental correlation analysis in patients undergoing nerve biopsy. Brain Pathology. 2026. doi:10.1111/bpa.70038

BibTeX
@article{Streit2026,
  author = {Streit, Simon and Meinhardt, Jenny and Gimber, Niclas and Kestenbach, John and Siewert, Christin and Schmoranzer, Jan and Meisel, Christian and Ruprecht, Klemens and Heppner, Frank L and Körtvélyessy, Péter and Stenzel, Werner},
  title = {Neurofilament light chain as a marker of peripheral nerve damage in vasculitic neuropathy? A cross‐compartmental correlation analysis in patients undergoing nerve biopsy},
  journal = {Brain Pathology},
  year = {2026},
  doi = {10.1111/bpa.70038}
}
Kostenlos starten →